# Lacosamide

NDC: 0121-2024
Generic name: Lacosamide
Labeler / Manufacturer: PAI Holdings, LLC dba PAI Pharma
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SOLUTION
Routes: ORAL
Marketing started: 20220826

FDA application: ANDA216151

## Active ingredients

- LACOSAMIDE: 100 mg/10mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0121-2024"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0121-2024
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=75de00d8-d2e7-4025-be4e-f49299068e7e